NCT03498729View on ClinicalTrials.gov

Autoimmunity in the Pathogenesis of AF

CompletedOBSERVATIONAL
Enrollment

75

Participants

Timeline

Start Date

March 5, 2018

Primary Completion Date

December 9, 2021

Study Completion Date

December 9, 2021

Conditions
Atrial Fibrillation
Interventions
OTHER

Peripheral Blood Sample

30mL peripheral whole blood sample

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Mayo Clinic

OTHER

NCT03498729 - Autoimmunity in the Pathogenesis of AF | Biotech Hunter | Biotech Hunter